Harry Jenkins

• Science & Technology

Detecting multiple cancers with a ‘simple' blood test: Where are we?

A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality? A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality?

14 April 2022

• Health & Medicine

New breast and lung cancer treatments approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer. 3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

19 January 2022

• Health & Medicine

New lung cancer treatment combo approved on NHS in England

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

12 January 2022

• Health & Medicine

Immunotherapy approved for some people with advanced melanoma in England

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer. The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

21 December 2021

• Science & Technology
• Health & Medicine

6 of the biggest good news cancer stories of 2021

From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021. From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021.

15 December 2021

• Health & Medicine

Over 600 people in England set to benefit from innovative lung cancer treatment

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence. More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

1 December 2021

• Health & Medicine

Childhood cancer survivors at greater risk of ill health

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe. People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.

22 November 2021

• Health & Medicine

Three cancer drugs approved for NHS use in Scotland

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

11 November 2021

• Science & Technology

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

25 October 2021

• Health & Medicine

Immunotherapy approved for some people with oesophageal cancer on NHS in England

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer. The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

20 October 2021

• Health & Medicine

New drug available for rare thyroid cancer on NHS in England

The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer. The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.

1 October 2021